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Multi-physics interactions drive 
VEGFR2 relocation on endothelial 
cells
Valentina Damioli1, Alberto Salvadori2,4, Gian Paolo Beretta  1, Cosetta Ravelli3,4 &  
Stefania Mitola3,4
Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) is a pro-angiogenic receptor, expressed 
on endothelial cells (ECs). Although biochemical pathways that follow the VEGFR2 activation are 
well established, knowledge about the dynamics of receptors on the plasma membrane remains 
limited. Ligand stimulation induces the polarization of ECs and the relocation of VEGFR2, either in 
cell protrusions or in the basal aspect in cells plated on ligand-enriched extracellular matrix (ECM). We 
develop a mathematical model in order to simulate the relocation of VEGFR2 on the cell membrane 
during the mechanical adhesion of cells onto a ligand-enriched substrate. Co-designing the in vitro 
experiments with the simulations allows identifying three phases of the receptor dynamics, which are 
controlled respectively by the high chemical reaction rate, by the mechanical deformation rate, and by 
the diffusion of free receptors on the membrane. The identification of the laws that regulate receptor 
polarization opens new perspectives toward developing innovative anti-angiogenic strategies through 
the modulation of EC activation.
Tyrosine Kinase Receptors (RTKs) transmit information from the extracellular to the intracellular microen-
vironment and play a central role in physiological and pathological conditions, including tumor progression. 
RTKs catalyze the phosphorylation of Tyrosine residues in their sequences as well as in second messengers. The 
non-homogeneous distribution of lipids and proteins on the cell membrane, both in space and time, is highly 
dynamic at multiple spatial levels and orchestrates the cellular response to different biochemical and mechanical 
inputs1. Membrane dynamics and composition2,3 also govern the expression and the activation of Epidermal 
Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor-2 (VEGFR2). The latter, 
expressed by cancer and ECs, modulates angiogenesis and tumor progression4–7 by binding different soluble lig-
ands, including VEGF-A, the non-canonical HIV-1-Tat8,9, and gremlin10,11. Thus, an abnormal spatial regulation 
of RTKs may play a role in cancer progression12. Most of VEGFR2 ligands contain a heparin binding domain and 
accumulate in the ECM, supporting a long-lasting activation of the cells. Moreover, ligand-enriched ECM recruits 
VEGFR2 at the basal aspect of ECs13,14, leading to a polarization of intracellular molecules.
Receptor-ligand interactions have been extensively studied from the biological and computational point of 
view. Several mathematical models have been developed to describe the body distribution of different isoforms 
of canonical and non canonical ligands of VEGFR2 and their interactions with VEGFRs both in vitro and in 
vivo15,16. These models confirmed that the amount of matrix-bound VEGF in normal human tissues (e.g. skeletal 
muscle) is 30 to 100-fold higher than the amount of free ligands17,18. Some models considered also receptor inter-
nalization, since similarly to other RTKs ligand interaction induces VEGFR2 endocytosis in early endosomes19. 
It is worth to point out that VEGFR2 undergoes efficiently in the endocytic compartment even in the absence of 
VEGF20,21. Mathematical models were also used to simulate and describe the competitive and/or synergic effects 
of different ligands on VEGFR2 interaction and biological cell responses22.
The goal of this study is threefold: formulating a mathematical model of VEGFR2 recruitment in EC, simulat-
ing the dynamics of VEGFR2 in EC seeded on ligand-enriched ECM, and finally co-designing experimental and 
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numerical investigations to characterize the dynamic lateral distribution (diffusion) of VEGFR2 receptors on the 
plasma membrane and their interactions (reaction) with immobilized ligands. The key features of our experimen-
tal evidence on VEGFR2 relocation are well captured by a diffusion-reaction model, whereby the evolving geom-
etry of the membrane is extremely simplified. The model is mathematically rigorous and self-consistent, in that 
it stems from continuity equations (for mass, energy, and entropy), standard chemical kinetics, thermodynamic 
restrictions, and constitutive specifications23,24. This sequence provides the governing equations in a strong form, 
stated for dimensionless unknown fields and converted in a weak form prior to the numerical approximation via 
the Finite Element Method. Thermodynamic parameters have been inferred from the experimental analyses and 
from the literature, whereas a few have been calibrated.
The present model will be further developed, to include the spreading/deformation of the cell, its focal adhe-
sion and the evolution of the stress fibers, the internalization of the complex, the ligand competition, ECM com-
position, co-receptor partners, and the cell cortex structure12,25. Moreover, the predictive capabilities of the model 
will be exploited in future studies to foresee alterations of the receptor behavior induced by mutations or admin-
istration of anti-angiogenic drugs.
Results
Free and immobilized ligands induce VEGFR2 rearrangement on EC plasma membrane. 
Different canonical and non canonical ligands, including VEGF-A, HIV-1-Tat, and gremlin are able to activate 
VEGFR2 and induce VEGFR2-mediated EC proliferation and migration9,10. To assess whether VEGFR2 redis-
tributes on the EC membrane when challenged by free ligands, adherent ECs over-expressing the Enhanced 
Yellow Fluorescent Protein (EYFP)-labeled extracellular domain (ECD) of VEGFR2 (ECD-VEGFR2-EYFP) 
were exposed for 2 hours to a linear concentration gradient of free ligands, including gremlin or VEGF-A, in a 
2D chemotaxis assay. According to our previous investigations data, ECD-VEGFR2-EYFP exerts binding and 
dimerization activities similar to the VEGFR2 full length10,11,14. Figure 1A shows that ECD-VEGFR2-EYFP is 
equally distributed on non-treated ECs (t0), while the gradient of ligands induces the ECD-VEGFR2-EYFP to 
be recruited in the lamellipodia at the leading edge of migrated ECs (t30). Together, these data demonstrate that 
free ligands are able to induce EC polarization, leading to VEGFR2 relocation on the surface of ECs. Although 
VEGFR2 ligands are usually considered as soluble molecules, in vivo they are bound and immobilized in the ECM 
or on the cell membrane by heparan-sulphate proteoglycans26.
Soluble and ECM-bound VEGF impact VEGFR2 trafficking rate. The clustering and the slower internali-
zation rate of VEGFR2 complexes activated by ECM-bound VEGF elicits a prolonged activation of VEGFR2 
and Extracellular signal Regulated Kinase (ERK) with a different pattern of site-specific phosphorylation14,27,28. 
To characterize the influence of the immobilized VEGFR2-ligands on the VEGFR2 rearrangement on the cell 
membrane, we plated ECs on ligand-coated cell plates. Similarly to immobilized gremlin14, immobilized VEGF-A 
induces the recruitment of VEGFR2 to the plasma membrane at the basal aspect of ECs, thus leading to a local-
ized and directional receptor activation (Fig. 1B). The concentration of VEGFR2 at the apical side of the cell is 
diminished by the recruitment of VEGFR2 at the basal portion of adherent cells, as demonstrated by the reduc-
tion of soluble ligand binding ability (Fig. 1C). Similar data were obtained with immobilized-VEGF-A.
Figure 1. VEGF-A and gremlin induce VEGFR2 rearrangement on EC surface. (A) ECD-VEGFR2-EYFP 
ECs were stimulated by a VEGF-A or gremlin gradient for 2 hours, fixed and analysed using a Zeiss Axiovert 
200M system (630×; white bar: 10 μm). Arrows indicate ECD-VEGFR2-EYFP-enriched cell lamellipodia. (B) 
HUVECs adherent on Fibrinogen or VEGF-A-enriched substrates were stained for VEGFR2 (green) and actin 
(red) and analysed using a LSM510 Meta confocal microscope. Images show the basal portion of adherent cells 
with the orthogonal z reconstruction of the whole cell (630×; white bar: 10 μm). (C) VEGFR2-EC, seeded on 
immobilized gremlin or on coverglass for 4 hours, were incubated with 150 ng/mL of gremlin for 90 minutes at 
4 °C and washed with 1.5 mol/L NaCl. VEGFR2-bound gremlin, in the apical portion of the cells, was detected 
by immunofluorescence analysis using a Zeiss Axiovert 200 M microscope system (630x; white bar: 10 μm). 
Data are expressed as percentage ± s.d. of gremlin positive area with respect to the total cell area (n = 20 cells/
sample; *P < 0.001, Student’s t-test).
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Ligand binding decreases VEGFR2 diffusion on plasma membrane. In order to measure the mobility of 
VEGFR2 on the cell membrane, we performed Fluorescence Recovery After Photobleaching (FRAP) analysis on EC 
culture expressing ECD-VEGFR2-EYFP. The rate of fluorescence recovery provides quantitative information about 
the kinetics of diffusion of fluorescent molecule in the photo-bleached area. To measure the dynamics of VEGFR2 on 
the cell membrane, fluorescence was recorded every minute for 10 minutes in an irreversibly photo-bleached mem-
brane region of ECD-VEGFR2-EYFP EC in the absence or in the presence of 50 ng/mL of VEGF-A or gremlin. In 
our experimental conditions, 77% of ECD-VEGFR2-EYFP in the plasma membrane turns out to be in a mobile form, 
with a lateral diffusion coefficient of 0.198 μm2/s in untreated ECs. Both VEGF-A or gremlin treatments decrease 
the receptor mobility respectively to 0.098 μm2/s and 0.052 μm2/s (Fig. 2). All these data highlight that non-activated 
receptors are mainly free to move on the cell membrane, thus suggesting that VEGFR2 phosphorylation, its dimeriza-
tion, and its interaction with membrane co-receptors or intracellular signaler reduce its motility. FRAP data support 
our former observations14 that VEGFR2 is rapidly recruited and immobilized in the membrane in close contact with 
ligands. These events lead to increase the receptor concentration in the basal side of the cell.
A chemo-transport-mechanical model describes VEGFR2 relocation on EC surface. We describe 
the relocation of VEGFR2 on the cell membrane during its adhesion to ligand-enriched ECM by means of a 
model that accounts for the ligands-receptors chemical interaction, the diffusion of receptors along the mem-
brane, and the mechanical deformation of the cell. It will be denoted henceforth as a chemo-transport-mechanical 
model. It is defined on the cell surface only, and it has been validated against co-designed experimental investi-
gations. The cell adhesion to a ligand-enriched substrate results in VEGFR2 polarization to the basal membrane 
and entails several concurrent phenomena, including cell deformation and cytoskeletal remodeling, which lead 
to an increased interaction between the basal cell membrane and the ligand enriched-substrate. While the intra-
cellular tail of VEGFR2 and in particular the tyrosine residues are required for the correct VEGFR2 internaliza-
tion29,30, the kinase domain is not required for the receptor relocation, as demonstrated either by the recruitment 
of VEGFR2 in the presence of the Sugen 541614 or by the recruitment of the receptor without its intracellular 
tail (ECD-VEGFR2). VEGFR2 polarization is not mediated by integrin interaction even though, once recruited, 
VEGFR2 will form an active complex with integrin in lipid rafts. We neglect accordingly the intracellular subset 
of VEGFR2 and the interaction with coreceptors in our chemo-transport-mechanical model. To simulate the 
interaction between VEGFR2 and its immobilized ligand, we assume a fixed membrane geometry and account 
for the effects of cell adhesion with a supply of ligands onto the cell surface at a prescribed rate, sL (ligands/μm2 s), 
detailed in Eq. (8). Figure 3 shows the spatial evolution of the mass supply sL and of the total amount of lig-
ands parametrized in time: at each location, ligands smoothly reach the saturation limit of 44.83 ligands/μm2 s 
(Fig. 3B). Owing to this modeling simplification, the actual time-evolving geometry of the membrane becomes 
relatively unimportant and thus, for maximal simplicity, we analyze it as a circumference of radius l = 20 μm and 
assume that the time-dependent concentrations depend on the curvilinear coordinate.
The model was implemented in a finite element code as a script in Wolfram Mathematica version 10 and 
calibrated. The simulations run until the final time tF = 7200 s at the constant temperature 310.15 K with a 
substrate-adsorbed ligand concentration of 44.83 ligands/μm2 (Fig. 3B).
Multi-physics drive the complex formation with three different mechanisms. As depicted in 
Fig. 4, that represents the overlay of the outcomes of simulation (green line) and in vitro experiments (red dots)14  
normalized to the value of VEGFR2 at the final time tF, VEGFR2 recruitment induced by immobilized ligands 
Figure 2. VEGF-A and gremlin reduce VEGFR2 motility on EC surface. (A) FRAP analysis was performed 
on cell plasma membrane of serum-starved ECD-VEGFR2-EYFP over-expressing GM7373 cells treated or not 
with VEGF-A or gremlin (50 ng/mL). Images were acquired at one per minute for 12 minutes, 2 before and 10 
after bleaching. The bleached area is indicated by a square and the recovery time is indicated over the images 
as seconds after photobleaching (630x; white bar: 20 μm). (B) Collected images were analyzed using simFRAP 
ImageJ plugin to calculate diffusion coefficients. The graph shows diffusion coefficient mean ± s.d. of control, 
VEGF-A, and gremlin treated cells (n = 7 – 15; *P < 0.01, Student’s t-test).
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shows three phases of complex formation marked by circled roman numbers: an initial plateau (I), a steep branch 
(II), and finally an evolution with a lower formation rate (III). Our numerical simulations allow connecting these 
three phases to three distinct mechanisms dominated by different limiting factors. The initial plateau is governed 
by the cell-ligand contact (I), the second steep phase (that ends at 600 s) is due to a chemo-mechanical evolution 
- induced by the cell attachment and deformation (II), and the final slow phase reflects the diffusive slow motion 
of the receptors from the apical to the basal membrane that is in contact with the substrate (III).
The quantitative correspondence between experimental and numerical outcomes suggests that the number of 
well-oriented ligands available for the receptor binding is much smaller than the total amount of immobilized lig-
ands. As shown in Fig. 4, the simulated evolution in time of the overall amount of bound VEGFR2-ligands com-
plex on the membrane overlaps the experimental outcomes we previously observed14, validating of the model.
The chemo-mechanical transport model describes VEGFR2 dynamics. Numerical simulations pre-
dict the evolution of the concentration of free receptors (cR) during 2 hours of cell stimulation. Figure 5A quanti-
fies cR at each location along the membrane at different times. Exploiting the axial symmetry of the simulations, 
each curve on the right side of Fig. 5A depicts the spatial concentration profile every minute. At t = 0 the distri-
bution of receptors is uniform at the concentration cR = 4.8 receptors/μm2. After 60 s, the concentration profile 
is perturbed and decreases at the bottom of the cell due to receptor-ligand complex formation. As time goes by, 
starting from 120 s, an enlarging zone with negligible concentration cR ~ 0 of free receptors is visible at the basal 
side of the cell (point A), due to the engagement of free receptors by immobilized ligands. At the end of the simu-
lation, at tF = 7200 s, the concentration of unbound receptors at the apical side amounts at cR = 0.5 receptors/μm2.
The chemo-mechanical transport model allows concluding that the depletion of free receptors is due to three 
concurrent factors: i) the infinitely fast kinetics of the ligand-receptor interaction; ii) the high equilibrium con-
stant, that favors the formation of ligand-receptor complex; iii) the evidence that diffusion of the receptor on the 
cell membrane is much slower than interaction kinetics.
Figure 3. Effects of cell deformation mimicked through a supply of ligands sL onto the membrane. (A) Spatial 
evolution of the mass supply sL and (B) of its time-cumulate.
Figure 4. Time evolution of the VEGFR2-gremlin complex formation on the EC membrane. Comparison is 
made between the VEGFR2 total fluorescence intensity (free and bound) in contact the substrate (red dots) and 
the numerical simulation data (green lines). To allow comparisons, both sets of data have been normalized to 
the values reached at the final time tF = 7200 s.
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The depletion “propagates” with time, so that at tf = 600 s, after the cell is completely adhered, the lower por-
tion of the cell membrane is essentially empty of free receptors. Since no further supply sL is provided afterwards, 
the process becomes diffusion-dominated, and it slowly evolves towards a final steady state. The thick blue curve 
plots the distribution of free receptors at the end of the simulation at time tF. The maximum concentration of free 
VEGFR2 at tF is 0.49 receptors/μm2 and a steady state has not yet been reached.
Ligand-receptor complex accumulates at the boundary of the EC basal membrane. Numerical 
simulations predict that after 2 hours of adhesion (at tF = 7200 s) a zone with high ligand-receptor complex con-
centration manifests at the boundary of the contact area. Figure 5B depicts the evolution of complex cC in space 
(X axis) and time (different colors) at the basal aspect of ECs. Such distribution profile was confirmed experimen-
tally in EC VPMs, as shown in Fig. 5C. VPMs were obtained by an osmotic shock of ECs, that preserves only the 
basal portion of cell membrane in close contact with ECM, allowing the visualization of the recruited receptors 
VGEFR2.
Discussion
VEGFR2 is a transmembrane protein, a key signal transducer in angiogenesis, and a potential therapeutic target 
in angiogenesis-related diseases. It has a lateral mobility of about 0.198 μm2/s, as measured in this work by means 
of FRAP experiments, and can interact with both soluble and ECM-immobilized ligands. Indeed several VEGFR2 
ligands contain one or more heparin binding domains in their sequences. After ligand interaction, VEGFR2 
dimerizes and transduces an intracellular signaling via its relocation on the cell membrane and the recruitment 
of intracellular proteins.
We developed a multi-physics model to describe and predict the effects of ligands on VEGFR2 relocation 
during the EC activation. The interaction between ligands and receptors has been modeled by a chemical reac-
tion that produces a complex, as customary in literature19,28. The model accounts for finite reaction kinetics, 
although simulations have been carried out assuming that the reaction kinetics is infinitely fast. The time-scale of 
Figure 5. The chemo-mechanical transport model describes VEGFR2 relocation dynamics. (A) Time evolution 
of the spatial concentration cR of free VEGFR2 along the cell membrane. Each curve plots the distribution of 
free receptors at different times t = 60 n, with n = 0, 1, 2, … 120 s from the beginning of the experiment at t = 0 
to the final time tF = 7200 s. (B) Spatial evolution of the concentration cC of the receptor-ligand complex at 
various times. The curves report the numerical simulation: points A, B, and C correspond to those in (A). (C) 
VPM staining for VEGFR2 confirms peaks in the intensity of fluorescence at the boundary of the substrate/
membrane contact surface.
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the VEGFR2-gremlin binding reaction is in fact assumed to be much faster than the time-scale of the mechan-
ical deformation of the cell and of the diffusion of receptors on cell membrane. Under these assumptions, we 
recovered the experimental evidence that the motion of receptors and their subsequent trapping into immobile 
VEGFR2-ligands complexes proceed in a sequence of three phases, and we characterized those phases with dif-
ferent rate-controlling factors. The first phase starts when a small portion of membrane gets in contact with the 
substrate, which provides a sudden supply of ligands that immediately trap the available receptors. This phase is 
very rapid, because the reaction rate is the controlling factor (in our model assumed infinite), and fully depletes 
the concentration of free receptors, because the equilibrium constant is very large. The second phase (calibrated 
in 10 minutes from experiments) is rate-controlled by the mechanical deformation of the cell, which provides 
additional supply of ligands that afresh immediately react with the available receptors on the newly formed con-
tact area. The mechanical deformation of the cell and the VEGFR2 recruitment14 are influenced by the chemi-
cal affinity of the VEGFR2-gremlin binding reaction coupled with intracellular cortical actin dynamics. In our 
co-designed experimental and theoretical study, the cell adhesion is not mediated by integrin engagement, even 
though integrin involvement cannot be completely ruled out. We observed that in our experimental conditions 
substrate-immobilized growth factors act as a cell-adhesive stimulus for ECs, which is weaker than the ECM13. 
Although a few papers consider the integrin-mediated focal adhesions and their interactions with the cytoskel-
eton31–33, they do not apply to our experimental conditions since the involved β3 integrin is not recruited in the 
focal adhesion complexes. Bound VEGFR2 forms a complex with β3 integrin in membrane lipid raft domains and 
not in focal adhesion. Our current simplified model does not capture the complexity of this binding. Instead, it 
surrogates the details of the mechanical deformation with the experimentally-guided assumption of an empirical 
ad-hoc time-sequence of gremlin supply on increasing portions of the cell membrane. The cell surface becomes 
depleted of free receptors very rapidly where the cell adheres to the substrate. When the mechanical deforma-
tion terminates and the cell is eventually spread, the diffusion of receptors becomes the rate-controlling mecha-
nism. During this final phase, receptors that diffuse through the boundary of the contact surface are immediately 
trapped and immobilized by the ligands on the substrate. Therefore, the VEGFR2-gremlin complex tends to accu-
mulate at the boundary of the basal aspect of the cells in close contact with ECM. Such a localization was observed 
in the ventral plasma membrane of ECs adherent on gremlin- or HIV-1 Tat13 enriched surfaces. A higher concen-
tration of receptors at the cell boundary could have relevant biological implications for the cell, which may sense 
ligand concentration variation and migrate in the direction of stimulus production.
The key features of our experimental evidence on VEGFR2 relocation are captured well. The effect of the 
mechanical deformation of the cell has been accounted for in the model, by surrogating the explicit description 
of the cell spreading/deformation with a given increase in time of the surface area available for the chemical reac-
tion. The model accounts for finite reaction kinetics, although simulations have been carried out assuming that 
the reaction kinetics is infinitely fast. Moreover, the model shown predictive capability. Numerical simulations 
highlighted a zone with high complex concentration at the boundary of the contact area at the final time of the 
simulations. This concentration were experimentally confirmed Fig. 5B and has been understood.
Other authors19 proposed meta-models that involve the integration of extracellular cues with intracellular 
processes, such as receptor endocytosis and phosphorylation. Those models are typically point-wise in nature 
and focus on the evolution in time disregarding the space distribution, so that ordinary differential equations suf-
fice. Modeling the motion of membrane receptors concurrently with several other aspects of endothelial biology 
(as internalization or cooperativity in ligand action) is more intricate and can only be dealt with incrementally, 
moving from simple yet not simplistic assumptions and adding complexities stepwise. The current model will 
be enriched toward the ambitious target of modeling the angiogenesis process as a whole. The role of kinetic 
constants will be investigated34–37, including internalization38,39 as well as the involvement of other co-receptors 
(including integrins and heparansulphateproteoglycans) and the cytoskeleton re-organization that leads to cell 
motility and morphogenesis. The interaction between the ligand complex and non engaged integrins will be con-
sidered, because β3 integrin mediates and triggers the long-lasting VEGFR2 activation14.
The surrogated mechanics will be replaced by a detailed analysis of the structural behavior of the cell, fol-
lowing recent studies31–33,40–42, thus coupling the evolution for the Laplace-Beltrami-like operator that presides 
the formulation with the large deformation of the cell. Mechanical models for cell spreading involve sophis-
ticated descriptions of active and passive behavior of cells with equations that are much harder to follow than 
the ones presented here. Simulations of these models require an impressive computational burden, so large that 
high performance computing is mandatory. In conclusion, there is a substantial increment of theoretical and 
computational complexity in adding further phenomena of endothelial biology. Since the simplified model with 
surrogated mechanics resulted capable to reproduce experimental evidences, we expect that the real mechanical 
evolution may add further insights and fine tune the results, without altering the general picture presented here. 
A simple yet effective surrogate model may have merits, though, and it will be used to save computational costs 
when it comes to perform uncertainty quantification studies, which require a large number of computationally 
expensive simulations.
Methods
Cell cultures. Foetal bovine aortic endothelial GM7373 cells43 were grown in Dulbecco’s modified Eagle 
medium (DMEM, Gibco, Life Technologies) containing 10% FCS, vitamins, essential and non-essential amino 
acids. GM7373 cells were transfected with a pcDNA3/Enhanced Yellow Fluorescent Protein (EYFP) vector har-
boring the extracellular domain of human VEGFR2 (ECD-VEGFR2) cDNA (provided by K. Ballmer-Hofer, PSI, 
Villigen, Swiss) to generate ECD-VEGFR2-EYFP EC14, or with a pcDNA3.1 vector harboring the mouse VEGFR2 
cDNA to generate stable GM7373-VEGFR2 (VEGFR2- ECs).
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Chemotaxis assay. This was performed as described44. Briefly, ECD-VEGFR2-EYFP overexpressing ECs 
were seeded at 3.0 × 106 cells/mL in μ-slide chemotaxis chambers (IBIDI, Martinsried, Germany) and incubated 
in complete medium for 24 hours. Cells were then stimulated with gremlin11 and VEGF-A (100 ng/mL)45 and 
observed during gradient formation. After 2 hours, cells were photographed under a Zeiss Axiovert 200 M epi-
fluorescence microscope equipped with a Plan-Apochromat 63x/1.4 NA oil objective. Z-stack images acquired 
using ApoTome imaging system were elaborated through AxioVision Extended Focus module (Zeiss Axiovert 
200 M system).
ECs adhesion on immobilized protein. 2.0 μg/mL of gremlin, VEGF or Fibrinogen (Fb) were added to 
polystyrene tissue culture plates or glass coverslips. After 16 hours of incubation at 4 °C, samples were washed 
and uncovered glass was blocked with 1.0 mg/mL bovine serum albumin (BSA) for 1 hour at room temperature14.
Ventral plasma membrane (VPM) preparation. VPMs were prepared by osmotic shock using a modi-
fication of the squirting lysis technique14. Briefly, cells were washed twice with ice-cold water; after 1 minute cells 
were squirted over by using a jet of ice-cold water and immediately fixed for immunocytochemistry analysis. In all 
the experiments, the absence of DAPI staining and the persistence of actin filaments were used to unequivocally 
identify the VPM remnants bound to the substratum. For total VEGFR2 staining, samples were incubated over-
night with a rabbit polyclonal anti-VEGFR2 antibody (1:200, Santa Cruz Biotechnology) followed by a 1-hour 
incubation with AlexaFluor 488-conjugated anti-rabbit IgG (1:500). For actin staining samples were incubated 
for 30 minutes with TRITC-phalloidin (0.9 mg/mL in PBS, Sigma). All reagent dilutions were in PBS containing 
3% BSA. VPMs were acquired under an Axiovert 200 fluorescence microscope equipped with a Plan-Apochromat 
63x/1.4 NA oil objective and ApoTome system (Carl Zeiss). VEGFR2-positive areas and total VPM areas, defined 
by actin staining, were quantified using Image-Pro Plus software.
Ligands/cell binding assay. GM7373-VEGFR2 (VEGFR2-ECs) cells were seeded on VEGF-A or gremlin 
or uncoated coverslip for 4 hours and then incubated with soluble gremlin (150 ng/mL) for 90 minutes at 4 °C 
in PBS added with Ca2+ and Mg2+ and 0.1% gelatin. Then, cells were washed three times with PBS or with 
PBS plus 1.5 mol/L NaCl to remove HSPGs-bound ligands. Immunofluorescence analysis was performed using 
a goat polyclonal anti-gremlin antibody (R&D Systems) or goat polyclonal anti VEGF-A antibody followed by 
AlexaFluor 488 anti-goat IgG (Molecular Probes, Life Technologies). Cells were analysed using a Zeiss Axiovert 
200 M system.
Fluoresence Recovery After Photobleaching (FRAP). ECD-VEGFR2-EYFP ECs were seeded at 
5.0 × 105 cells/mL μ-slides (IBIDI, Martinsried, Germany). Cells were starved in minimal medium for 4 hours, 
stimulated with gremlin or VEGF-A (50 ng/mL) and analysed using LSM510-META confocal microscope 
equipped with an incubation chamber (Zeiss). Confocal images were recorded with 4–5% of the intensity of 
the 514-nm line from living transfected cells. EYFP fluorescence was eliminated using a 350-iteration bleach 
cycle at 100% intensity of the 514-nm line. Control bleach experiments performed over the entire cell surface 
demonstrated that the EYFP chromophore was completely inactivated by this treatment and that recovery of flu-
orescence due to newly synthesized EYFP proteins was not detectable during the period of recovery (10 minutes). 
Image series were analysed using simFRAP ImageJ plugin (https://imagej.nih.gov/ij/plugins/sim-frap/index.
html)46. To calculate diffusion coefficients and using FRAP Caculator ImageJ macro (https://www.med.unc.edu/
microscopy/resources/imagej-plugins-and-macros/frap-calculator-macro) to calculate mobile and immobile 
fractions following author instructions.
Data representation. Data are expressed as mean ± SD or mean ± SEM. Statistical analyses were performed 
using the Student’s t-test. The significance level was set at P < 0.01.
Chemo-transport-mechanical model formulation. A general formulation for the chemo-transport- 
mechanics problem with trapping is here tailored to model the relocation of VEGFR2 on the lipid bilayer membrane. The 











The ligand, whose degradation is negligible, and the complex are assumed to be immobile. Complex internaliza-
tion and the return back to the surface will be elaborated in future publications. Since receptors are free to move 
along the membrane, reaction (1) portrays a conversion of mobile to trapped receptors and vice-versa. Its rate 
































Since Eq. (2) are defined on the cell membrane only, derivatives in the divergence operator are defined on a 
curved surface, in the Laplace-Beltrami sense. Concentrations cR, cL, cC (molecules/μm2) are constrained fields, 
since they must be positive and cannot exceed the saturation amounts cR
max, cL
max, cC
max, respectively. Symbol sL 
denotes a mass supply (molecules/μm2 s), which will be illustrated later in the paper. Vector 
→
hR (molecules/sμm) 
denotes the flux of receptors along the membrane surface. It is constitutively described by a Fickian law, by means 
of the tangential gradient of the concentration,
→
= − ∇h cD [ ], (3)R R R
thus entailing the Clausius-Duhem inequality. Symbol DR denotes the receptors’ diffusivity along the membrane 
























where ±k1  denote the forward (+) and reverse (−) rate constants (molecules/μm2 s) for reaction (1), θ = c c/J J J
max 






















































(1) is the equilibrium constant and μ μ μ∆ = − −G C R L(1)
0 0 0 0 is the Gibbs free energy of the reaction.
Mass balance equation (2) shall be accompanied by the balance of force, to model the mechanical (and thus 
geometrical) evolution of the cell shape, whose boundary - the membrane - is the geometrical support of Eq. (2). 
Modeling the evolution of the Laplace-Beltrami operator that presides formulation (2–4) concurrently with the 
large deformation of the cell is a phenomenally ambitious task, which is in progress motivated by the promising 
outcomes here shown. In the present work, we surrogate the mechanics with some simplifying assumptions. They 
are collected in the following section.
Simplifying assumptions. Two major simplifications, pertaining to reaction kinetics and mechanical mod-
eling, will be undertaken henceforth. They allow verifying the capability of the chemo-transport model (2–4) to 
reproduce experimental evidences with much less theoretical and computational burden.
The assumption is taken henceforth that the reaction kinetics is infinitely fast, considering that the time 
required to reach chemical equilibrium is orders of magnitude smaller than the time-scale of the other processes. 
This assumption is usually taken in conceptually similar problems, as the diffusion of species in metals48 or the 
electro-mechanics of batteries49–53. Then, concentration of the complex is governed by thermodynamic equilib-
rium at all times by Eq. (5), which with trivial algebra becomes:
c c c c
K
( , ) 1 1 1 1
(6)



























The two final parabolic governing equations in the unknown fields cL and cR can be easily inferred from Eqs 





h( , ) div[ ] 0, (7a)




















s( , ) (7b)
L C L R
L
The change of the geometry of the membrane with time is dictated by the mechanical evolution of the cell, 
which in turn is governed by several complex phenomena (such as focal adhesion and stress-fiber reorganiza-
tion32, integrins-ECM interactions54, curvature changes of cell membrane55, cooperation between integrins and 
VEGFR245,56) triggered by the adhesion of the cell onto the ligand-coated plate described in the experimental sec-
tion. Roughly, adhesion induces cells to deform from an initially spherical shape to a final spread configuration33,57, 
resulting in increased interaction between basal cell membrane and the ligand enriched-substrate. We replace the 
explicit modeling of cell spreading/deformation with a supply of ligands sL, calibrated from experimental data and 
included in Eq. (7) in order to simulate the interaction between basal cell membrane and the substrate.
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We assume therefore that the membrane geometry is fixed and thus account for the effects of cell adhesion 
by a supply of gremlin on the membrane at a prescribed rate, sL (molecules/μm2 s), inferred from experimental 
evidence and defined as follows:


























and plot in Fig. 3. In Eq. (8)  is the Heaviside step function, c 72 ligands/ mL
2μ=  is the concentration of 
substrate-immobilized ligand available for reaction (1), tf is the time required for the complete mechanical defor-
mation of the cell, v t/2 fπ=  is the velocity of mechanical deformation (assumed to be constant until tf),  is the 
cell radius, t t f  is a parameter that identifies a finite time required for binding, x is the curvilinear abscissa of 
our simplified geometry, t the generic time. In view of Eq. (8), the supply of ligands at point x on the membrane 
remains zero until t < x/v; then, in the time span between t = x/v and = +t x v t/ , it increases rapidly from zero 
to cL.
Weak form and discretization. The governing equations for the relocation of VEGFR2 on the membrane 
under the above modeling assumptions have been made dimensionless and multiplied by test functions. The 
weak form obtained by their integration over the spatial domain can be transformed to a first order Ordinary 
Differential Equation (ODE) in time if the discretization is performed via separated variables. Therefore, nodal 
unknowns depend solely on time, while test and shape functions solely on space. Time advancing has been 
achieved by finite differences, using a backward Euler scheme. Discretization of the unknown fields by means of 
standard linear shape functions leads to the numerical approximation via the finite element method in each time 
step.
Material parameters. Parameters for the in silico simulation (see Table 1) were defined by in vitro assays. 
The cell radius was calculated from the measure of radius of 50 ECs using Zeiss Axiovert 200 M microscope; 
receptor diffusivity was obtained by FRAP analysis (see above). The amount of VEGFR2 on cell membrane per 
area was calculated by dividing the number of high affinity binding sites, obtained by radiolabeled binding exper-
iments58 for cell surface area. The kinetic parameters ligand/receptor were measured by Surface plasmon res-
onance (SPR) measurements (BIAcore X, GE Healthcare). The extracellular domain of human VEGFR2 was 
immobilized onto CM5 sensorchips (BIAcore) and increasing concentrations (from 100 ng/mL to 4 μg/mL) of 
ligand was injected in HBS-EP buffer (BIAcore) for 10 minutes (sample volume: 50 μL; flow rate: 5 μL/minute; 
dissociation time: 2 minutes). Binding parameters were calculated by the nonlinear-curve-fitting software pack-
age BIAevaluation 3.2 (Biacore)58. The maximal surface density of immobilized ligand on surface was determined 
by SPR. The sensorgram recorded during immobilization gives direct check on the amount of ligand attached to 
the surface. Full details and references about this procedure can be found at the dedicated page of the SPR pages 
website: http://www.sprpages.nl/Experiments/Howmuch.php.
Model calibration. Analyzing the evolution in time of VEGFR2 recruitment induced by immobilized lig-
ands experimentally measured in14 as fluorescence intensity of the overall VEGFR2 (free and bound), three 
phases of complex formation were identified, namely: an initial plateau, lasting few seconds; a steep branch, that 
takes place until about 600 s; and finally an evolution with a lower formation rate after the first 600 s. Accordingly, 
we calibrated tf = 600 s as the time for completion of the mechanical deformation and =t s1  as the parameter that 
identifies a finite time required for binding.
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